Abstract
To identify compounds with strong mPGES-1 inhibitory activity and clear in vitro ADME profile, we optimized the lead compound 1 by carrying our substitutions at the C(7)- and C(8)-positions. Replacement of the bromine atom of 1 with various substituents led to identification of the phenyl group as the best C(7)-substituent giving strong inhibitory activity with good in vitro ADME profile. Further SAR examination on both the C(2)- and the C(7)-phenyl groups provided compound 39 as the best candidate for further development. Compound 39 exhibited strong mPGES-1 inhibitory activity (IC50=4.1 nM), potent cell-based functional activity (IC50=33 nM) with good mPGES-1 selectivity (over 700-fold), excellent in vitro ADME profile, and good oral absorption in rat PK study.
Copyright © 2013 Elsevier Ltd. All rights reserved.
MeSH terms
-
Administration, Oral
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis*
-
Anti-Inflammatory Agents, Non-Steroidal / chemistry
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics*
-
Biological Availability
-
Cytochrome P-450 Enzyme System / chemistry
-
Cytochrome P-450 Enzyme System / metabolism
-
Drug Discovery
-
Drug Stability
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacokinetics*
-
HEK293 Cells
-
Humans
-
Imidazoles / chemical synthesis*
-
Imidazoles / chemistry
-
Imidazoles / pharmacology
-
Inhibitory Concentration 50
-
Prostaglandin-E Synthases
-
Prostaglandin-Endoperoxide Synthases / chemistry*
-
Prostaglandin-Endoperoxide Synthases / metabolism
-
Quinolones / chemical synthesis*
-
Quinolones / chemistry
-
Quinolones / pharmacology
-
Rats
-
Sensitivity and Specificity
-
Structure-Activity Relationship
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Enzyme Inhibitors
-
Imidazoles
-
Quinolones
-
Cytochrome P-450 Enzyme System
-
Prostaglandin-Endoperoxide Synthases
-
Prostaglandin-E Synthases
-
Ptges protein, rat